The VEGF splice variants: Properties, receptors, and usage for the treatment of ischemic diseases

Herz

Volumn 25, Issue 2, 2000, Pages 126-129

  Poltorak, Zoya ^b   Cohen, Tzafra ^b   Neufeld, Gera ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b NONE

Author keywords

Angiogenesis; Neuropilin; Splice forms; Vascular endothelial growth factor (VEGF)

Indexed keywords

VASCULOTROPIN;

ALTERNATIVE RNA SPLICING; ANGIOGENESIS; EXON; GENE EXPRESSION; HUMAN; HYPOXIA; ISCHEMIA; PROTEIN BINDING; PROTEIN DOMAIN; RECEPTOR BINDING; REVIEW;

EID: 0034008827     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00001950     Document Type: Review

References (32)

1. Arveschoug A, Christensen KS. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia [letter]. Circulation 1999;99:2967-8.
2. Bacic M, Edwards NA, Merrill MJ. Differential expression of vascular endothelial growth factor (vascular permeability factor) forms in rat tissues - Short communication. Growth Factors 1995;12:11-5.
3. Banai S, Shweiki D, Pinson A, et al. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994;28:1176-9.
4. Brogi E, Wu TG, Namiki A, et al. Indirect angiogenic cytokines up-regulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994;90:649-52.
5. Chen H, Chedotal A, He Z, et al. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron 1997;19:547-59.
6. Enholm B, Paavonen K, Ristimaeki A, et al. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia. Oncogene 1997;14:2475-83.
7. Gengrinovitch S, Berman B, David G, et al. Glypican-1 is a VEGF165 binding proteoglycan that acts as an extracellular chaperone for VEGF165. J Biol Chem 1999;274:10816-22.
8. Gitay-Goren H, Cohen T, Tessler S, et al. Selective binding of VEGF121 to one of the three VEGF receptors of vascular endothelial cells. J Biol Chem 1996;271:5519-23.
9. Houck KA, Ferrara N, Winer J, et al. The vascular endothelial growth factor family-identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991;5:1806-14.
10. Kawasaki T, Kitsukawa T, Bekku Y, et al. A requirement for neuropilin-1 in embryonic vessel formation. Development 1999;126: 4895-902.
11. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989;246: 1309-12.
12. Kolodkin AL, Ginty DD. Steering clear of sema phorins: Neuropilins sound the retreat. Neuron 1997;19:1159-62.
13. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246: 1306-9.
14. Losordo DW, Vale PR, Symes JF, et al. Gene therapy for myocardial angiogenesis - initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 1998;98:2800-4.
15. Mack CA, Patel SR, Schwarz EA, et al. Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg 1998;115:168-76.
16. Miao HQ, Soker S, Feiner L, et al. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility. Functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 1999;146:233-42.
17. Neufeld G, Cohen T, Gitay-Goren H, et al. Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev 1996;15:153-8.
18. Neufeld G, Cohen T, Gengrinovitch S, et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999;13:9-22.
19. Park JE, Keller GA, Ferrara N. Vascular endothelial growth factor (Vegf) isoforms-differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound Vegf. Mol Biol Cell 1993;4:1317-26.
20. Patel SR, Lee LY, Mack CA, et al. Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121. Hum Gene Ther 1999;10:1331-48.
21. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potent tumour angiogenesis factor in human gliomas in-vivo. Nature 1992;359:845-8.
22. Poltorak Z, Cohen T, Sivan R, et al. VEGF145: a secreted VEGF form that binds to extracellular matrix. J Biol Chem 1997;272: 7151-8.
23. Ramasamy S, Lipke DW, Mcclain CJ, et al. Tumor necrosis factor reduces proteoglycan synthesis in cultured endothelial cells. J Cell Physiol 1995;162:119-26.
24. Rosengart TK, Lee LY, Patel SR, et al. Angiogenesis gene therapy - phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease. Circulation 1999;100:468-74.
25. Schultz A, Lavie L, Hochberg I, et al. Interindividual heterogeneity in the hypoxic regulation of VECF -Significance for the development of the coronary artery collateral circulation. Circulation 1999;100:547-52.
26. Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-5.
27. Soker S, Takashima S, Miao HQ, et al. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 1998;192:735-45.
28. Takahashi T, Fournier A, Nakamura F, et al. Plexin-neuropilin-1 complexes form functional semaphoring receptors [In Process Citation]. Cell 1999;99:59-69.
29. Tamagnone L, Artigiani S, Chen H, et al. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates [In Process Citation]. Cell 1999;99: 71-80.
30. Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989;165: 1198-1206.
31. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991;266:11947-54.
32. Tsurumi Y, Kearney M, Chen DR, et al. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene. Circulation 1997;96:382-8.